News headlines about Align Technology (NASDAQ:ALGN) have been trending somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Align Technology earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 46.5765009994645 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Here are some of the news headlines that may have impacted Accern’s rankings:
- Align Technology, Inc. (ALGN): Consensus Estimates and Trading Data – Market Movers (financialqz.com)
- Align Technology, Inc. (ALGN) Receives Consensus Recommendation of “Buy” from Brokerages (americanbankingnews.com)
- ALGN Crosses Above Average Analyst Target (nasdaq.com)
- Align Technology, Inc. (ALGN) : Analysts Watch-List Stock – Wall Street Morning (wallstreetmorning.com)
- Notable Tuesday Option Activity: PYPL, ALGN, PSA (nasdaq.com)
ALGN has been the topic of several research reports. Stifel Nicolaus restated a “buy” rating and issued a $225.00 target price (up previously from $205.00) on shares of Align Technology in a research note on Thursday, October 19th. Morgan Stanley restated an “overweight” rating and issued a $220.00 target price (up previously from $195.00) on shares of Align Technology in a research note on Friday, October 6th. Zacks Investment Research upgraded Align Technology from a “hold” rating to a “buy” rating and set a $227.00 target price on the stock in a research note on Monday, October 30th. Credit Suisse Group upgraded Align Technology to a “buy” rating and set a $276.00 target price on the stock in a research note on Thursday, January 4th. Finally, Northcoast Research restated a “buy” rating and issued a $230.00 target price (up previously from $200.00) on shares of Align Technology in a research note on Tuesday, October 10th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $236.23.
Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.19. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The business had revenue of $385.30 million for the quarter, compared to analysts’ expectations of $359.80 million. During the same quarter in the prior year, the business earned $0.63 EPS. The firm’s revenue for the quarter was up 38.3% on a year-over-year basis. sell-side analysts expect that Align Technology will post 3.67 earnings per share for the current year.
In related news, VP Julie Tay sold 3,500 shares of the stock in a transaction on Monday, November 13th. The stock was sold at an average price of $253.00, for a total value of $885,500.00. Following the sale, the vice president now owns 12,213 shares in the company, valued at approximately $3,089,889. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CMO Raphael Pascaud sold 5,400 shares of the stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $241.88, for a total value of $1,306,152.00. Following the completion of the sale, the chief marketing officer now owns 22,228 shares in the company, valued at approximately $5,376,508.64. The disclosure for this sale can be found here. In the last 90 days, insiders sold 52,849 shares of company stock worth $13,494,348. 1.60% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Align Technology (ALGN) Share Price” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.chaffeybreeze.com/2018/01/19/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-align-technology-algn-share-price.html.
About Align Technology
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.